Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic targeting of replicative immortality
Paul Yaswen, Karen L. MacKenzie, W. Nicol Keith, et al.
Seminars in Cancer Biology (2015) Vol. 35, pp. S104-S128
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related Diseases
Pierpaola Davalli, Tijana Mitić, Andrea Caporali, et al.
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 867
JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Protein post-translational modifications in the regulation of cancer hallmarks
Haiying Wang, Liqian Yang, Minghui Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 529-547
Closed Access | Times Cited: 79
Therapeutic Targeting of Telomerase
Kathrin Jäger, Michael Walter
Genes (2016) Vol. 7, Iss. 7, pp. 39-39
Open Access | Times Cited: 131
Hydroxytyrosol protects from aging process via AMPK and autophagy; a review of its effects on cancer, metabolic syndrome, osteoporosis, immune-mediated and neurodegenerative diseases
Rocío M. de Pablos, Ana M. Espinosa‐Oliva, Ruth Hornedo‐Ortega, et al.
Pharmacological Research (2019) Vol. 143, pp. 58-72
Closed Access | Times Cited: 118
New prospects for targeting telomerase beyond the telomere
Greg M. Arndt, Karen L. MacKenzie
Nature reviews. Cancer (2016) Vol. 16, Iss. 8, pp. 508-524
Closed Access | Times Cited: 111
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
Juliana C. Santos, Estefanía Carrasco‐García, Mikel García-Puga, et al.
Cancer Research (2016) Vol. 76, Iss. 22, pp. 6735-6746
Open Access | Times Cited: 109
p53 Isoforms and Their Implications in Cancer
Maximilian Vieler, Suparna Sanyal
Cancers (2018) Vol. 10, Iss. 9, pp. 288-288
Open Access | Times Cited: 108
Current status of nanomaterial-based treatment for hepatocellular carcinoma
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 116, pp. 108852-108852
Open Access | Times Cited: 106
ST6GAL1: A key player in cancer (Review)
Rebecca Garnham, Emma Scott, Karen E. Livermore, et al.
Oncology Letters (2019)
Open Access | Times Cited: 104
Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development
André J. van Wijnen, Leila Bagheri, Amr A. Badreldin, et al.
Bone (2020) Vol. 143, pp. 115659-115659
Closed Access | Times Cited: 80
Plants as a Source of Anticancer Agents: From Bench to Bedside
Wamidh H. Talib, Safa Daoud, Asma Ismail Mahmod, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4818-4818
Open Access | Times Cited: 45
Aging, Cancer, and Inflammation: The Telomerase Connection
Virginia Boccardi, Luigi Marano
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8542-8542
Open Access | Times Cited: 13
Allicin and Cancer Hallmarks
Wamidh H. Talib, Media Mohammed Baban, Aya O. Azzam, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1320-1320
Open Access | Times Cited: 12
Molecular Basis of Cancer
Lalima Tiwari, Omar Kujan
(2024), pp. 415-428
Closed Access | Times Cited: 8
Gold nanoparticles, radiations and the immune system: Current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy
Nikolaos M. Dimitriou, George Tsekenis, Evangelos C. Balanikas, et al.
Pharmacology & Therapeutics (2017) Vol. 178, pp. 1-17
Open Access | Times Cited: 67
Premature aging/senescence in cancer cells facing therapy: good or bad?
Llilians Calvo Gonzalez, Sabrina Ghadaouia, Aurélie Martinez, et al.
Biogerontology (2015) Vol. 17, Iss. 1, pp. 71-87
Closed Access | Times Cited: 65
P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment
Rong-Jane Chen, Pei‐Hsuan Wu, Chi‐Tang Ho, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 8, pp. e2985-e2985
Open Access | Times Cited: 64
Targeting telomerase for its advent in cancer therapeutics
Shalini Bajaj, Maushmi S. Kumar, Godefridus J. Peters, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1871-1919
Closed Access | Times Cited: 54
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA)
Jaber Haj Ali, Michael Walter
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
HSP90 multi-functionality in cancer
Zarema Albakova
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Anticancer potential of garlic bioactive constituents: Allicin, Z-ajoene, and organosulfur compounds
Wamidh H. Talib, Sally Atawneh, Areen Nabil Shakhatreh, et al.
Pharmacia (2024) Vol. 71, pp. 1-23
Open Access | Times Cited: 6
Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma
Alyaa Dawoud, Ramez Elmasri, A.H. Mohamed, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104312-104312
Closed Access | Times Cited: 6
Epstein–Barr Virus in Gliomas: Cause, Association, or Artifact?
Saghir Akhtar, Semir Vranić, Farhan Cyprian, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 51
Telomerase gene therapy: a remission toward cancer
Sameer Quazi
Medical Oncology (2022) Vol. 39, Iss. 6
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top